Acceptability and tolerability of risankizumab maintenance therapy administered via on-body injector in patients with Crohn's disease: Results of the ACCEPT-OBI study. uri icon

authors

  • Buisson, Anthony
  • Vuitton, Lucine
  • Hebuterne, Xavier
  • Caillo, Ludovic
  • Blain, Antoine
  • Laharie, David
  • Peyrin-Biroulet, Laurent
  • Altwegg, Romain
  • Guillaume Le Cosquer, MD, PhD
  • Pereira, Bruno
  • Fumery, Mathurin
  • Gebara, Karim
  • Caron, Bénédicte
  • Boschetti, Gilles
  • Gilletta de Saint Joseph, Cyrielle
  • Nachury, Maria
  • Brixi, Hedia
  • Juillerat, Pascal
  • Serrero, Mélanie

publication date

  • September 10, 2026